Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Robert Ryan

Joins CRO's new Strategic Advisory Services unit

INC Research Robert RyanINC Research has appointed Robert Ryan as vice president of regulatory strategy, consulting and submissions within its new Strategic Advisory Services unit.

He joins the contract research organisation (CRO) from CNS and pain-focused pharmaceutical development company Levare, where he was chairman of the board.

Prior to this Ryan spent time with other CROs and biopharmaceutical companies, including Quintiles, PPD, Celtic Therapeutics and Schwarz Pharma.

In his new role at INC Ryan will be tasked with positioning INC's new Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

Tim Dietlin, senior vice president of global consulting and strategic alliances, said: "Robert brings a unique blend of strategic leadership skills and international regulatory expertise that speaks to biopharmaceutical companies looking for guidance along the entire continuum of the drug development life cycle.

"Our Regulatory Consulting and Submissions team has a long history of exceptional work, and we look forward to continuing this track record under Robert's leadership."

10th December 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics